Bal Pharma Ltd.
|
Cash Flow
|
|
You can view the
Cash Flow
for the last 5 years.
Market Cap. (Rs.)
|
154.41 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
40.43
|
52 Week High/Low (Rs.)
|
132/70
|
FV/ML
|
10/1
|
P/E(X)
|
60.05
|
Bookclosure
|
25/09/2023
|
EPS (Rs.)
|
1.63
|
Div Yield (%)
|
1.02
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
Net Profit/Loss Before Extraordinary Items And Tax | 4.75 | 9.18 | 4.10 | -13.53 | -0.20 |
| | | | | |
Net CashFlow From Operating Activities | -1.84 | 27.71 | 21.78 | 23.10 | 7.76 |
Net Cash Used In Investing Activities | -22.18 | -9.48 | -4.98 | -4.71 | -8.04 |
Net Cash Used From Financing Activities | 24.40 | -18.13 | -16.63 | -19.97 | 0.01 |
| | | | | |
Net Inc/Dec In Cash And Cash Equivalents | 0.37 | 0.09 | 0.16 | -1.58 | -0.27 |
Cash And Cash Equivalents Begin of Year | 1.11 | 1.02 | 0.86 | 2.44 | 2.71 |
Cash And Cash Equivalents End Of Year | 1.49 | 1.11 | 1.02 | 0.86 | 2.44 |